OBJECTIVE: To investigate the association between HIV viremia exposure during antiretroviral therapy (ART) and cardiovascular disease (CVD) risk.DESIGN: Nationwide observational cohort.METHODS: Participants (age > 15 years) from the Swedish nationwide InfCareHIV register initiating ART 1996-2017 were categorized in a time-updated manner into four viremia categories, starting from 12 months after ART initiation: suppression (<50 copies/ml), low-level viremia (50-199 copies/ml and 200-999 copies/ml, respectively), and high-level viremia (≥1000 copies/ml). In addition, cumulative viremia was estimated as the area under the log viral load (VL) curve. Proportional subhazard models adjusted for sex, age, pre-ART CD4 and VL, injection drug use, an...
OBJECTIVE: To determine the prevalence of risk factors for cardiovascular disease (CVD) among HIV-in...
OBJECTIVE: Metabolic changes caused by antiretroviral therapy (ART) may increase the risk of coronar...
Objective: To determine cardiovascular disease in different stages of HIV/AIDS and its associated ri...
OBJECTIVE: To investigate the association between HIV viremia exposure during antiretroviral therapy...
Aims: HIV-infected patients receiving combination antiretroviral therapy may experience metabolic co...
AIMS: HIV-infected patients receiving combination antiretroviral therapy may experience metabolic co...
Aims: HIV-infected patients receiving combination antiretroviral therapy may experience metabolic co...
AIMS: HIV-infected patients receiving combination antiretroviral therapy may experience metabolic co...
Aims HIV-infected patients receiving combination antiretroviral therapy may experience metabolic com...
AIMS: HIV-infected patients receiving combination antiretroviral therapy may experience metabolic co...
Chronic inflammation is an HIV infection feature, contributing to elevated risk of cardiovascular di...
Aims HIV-infected patients receiving combination antiretroviral therapy may experience metabolic com...
Objective: To determine the prevalence of risk factors for cardiovascular disease (CVD) among HIV-in...
OBJECTIVE: Metabolic changes caused by antiretroviral therapy (ART) may increase the risk of coronar...
Objective: To determine the prevalence of risk factors for cardiovascular disease (CVD) among HIV-in...
OBJECTIVE: To determine the prevalence of risk factors for cardiovascular disease (CVD) among HIV-in...
OBJECTIVE: Metabolic changes caused by antiretroviral therapy (ART) may increase the risk of coronar...
Objective: To determine cardiovascular disease in different stages of HIV/AIDS and its associated ri...
OBJECTIVE: To investigate the association between HIV viremia exposure during antiretroviral therapy...
Aims: HIV-infected patients receiving combination antiretroviral therapy may experience metabolic co...
AIMS: HIV-infected patients receiving combination antiretroviral therapy may experience metabolic co...
Aims: HIV-infected patients receiving combination antiretroviral therapy may experience metabolic co...
AIMS: HIV-infected patients receiving combination antiretroviral therapy may experience metabolic co...
Aims HIV-infected patients receiving combination antiretroviral therapy may experience metabolic com...
AIMS: HIV-infected patients receiving combination antiretroviral therapy may experience metabolic co...
Chronic inflammation is an HIV infection feature, contributing to elevated risk of cardiovascular di...
Aims HIV-infected patients receiving combination antiretroviral therapy may experience metabolic com...
Objective: To determine the prevalence of risk factors for cardiovascular disease (CVD) among HIV-in...
OBJECTIVE: Metabolic changes caused by antiretroviral therapy (ART) may increase the risk of coronar...
Objective: To determine the prevalence of risk factors for cardiovascular disease (CVD) among HIV-in...
OBJECTIVE: To determine the prevalence of risk factors for cardiovascular disease (CVD) among HIV-in...
OBJECTIVE: Metabolic changes caused by antiretroviral therapy (ART) may increase the risk of coronar...
Objective: To determine cardiovascular disease in different stages of HIV/AIDS and its associated ri...